The current role of thrombolytic therapy for pulmonary embolism

Seminars in Vascular Surgery

Volumn 13, Issue 3, 2000, Pages 217-220

  Goldhaber, S Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; UROKINASE;

BLEEDING; BLOOD CLOT LYSIS; CATHETER; CLINICAL TRIAL; DRUG EFFICACY; EMBOLECTOMY; FIBRINOLYTIC THERAPY; HEART RIGHT VENTRICLE FAILURE; HUMAN; LUNG EMBOLISM; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THROMBECTOMY;

CARDIAC OUTPUT, LOW; CATHETERIZATION, PERIPHERAL; EMBOLECTOMY; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; PULMONARY EMBOLISM; RISK FACTORS; THROMBOLYTIC THERAPY; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 0033818483     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
2. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial
3. Cardiovascular risk stratification of pulmonary embolism in patients
4. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism
5. Echocardiography Doppler in pulmonary embolism: Right ventricular dysfunction as predictor of mortality
6. Right ventricular dysfunction after acute pulmonary embolism: Pathophysiologic factors, detection, and therapeutic implications
7. Management strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry
8. Impact of thrombolytic treatment on the prognosis of hemodynamically stable patients with major pulmonary embolism: Results of a multicenter registry
9. A national cooperative study
10. Phase 2 results: A cooperative study
11. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trial
12. Alteplase versus heparin in acute pulmonary embolism: Randomised trial assessing right ventricular function and pulmonary perfusion
13. Recovery of regional right ventricular function after thrombolysis for pulmonary embolism
14. Thrombolytic therapy for pulmonary embolism: Frequency of intracranial hemorrhage and associated risk factors
15. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism: Consideration of noninvasive management
16. Increasing age is a major risk factor for hemorrhagic complications following pulmonary embolism thrombolysis
17. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism
18. Similarity in resentation and response to thrombolysis among women and men with pulmonary embolism
19. Attentuation over 24 hours of the efficacy of pulmonary embolism thrombolysis among cancer patients
20. Rapid haemodynamic improvement following saruplase in recent massive pulmonary embolism
21. Hemodynamic effects of double bolus reteplase versus alteplase infusion in a massive pulmonary embolism
22. Recombinant staphylokinase thrombolysis in patients with acute pulmonary embolism
23. Integration of catheter thrombectomy into our armamentarium to treat acute pulmonary embolism
24. Fragmentation of massive pulmonary embolism using a pigtail rotation catheter
25. A new treatment for severe pulmonary embolism: Percutaneous rheolytic thrombectomy
26. The urgent pulmonary embolectomy: Mechanical resuscitation in the operating theatre determines the outcome